NVS · Novartis AG · Financials
$140.77
-4.94 (-3.39%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$276.48B
Shares
1.90B
Volume · Sep 30
3.06M
Avg daily vol (3M)
1.93M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$54.53B
+8.4%
FY2025
Net Income
$13.98B
+17.1%
FY2025
Gross Margin
78.81%
+1.5pp
FY2025
Operating Margin
32.36%
+3.5pp
FY2025
Diluted EPS
$7.15
+21.8%
FY2025
Operating Cash Flow
$19.14B
+8.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $13.7B | $12.83B | $12.47B | $11.58B | $11.74B | $15.12B | $14.43B | $14.51B | $13.63B | $17.52B | $17.4B | |
| $42.98B | $38.9B | $34.19B | $31.88B | $32.24B | $34.78B | $34.25B | $31.59B | $29.77B | $31.92B | $32.98B | |
| $11.2B | $10.02B | $11.37B | $9.17B | $8.64B | $8.98B | $9.4B | $8.49B | $8.39B | $9.04B | $8.94B | |
| — | — | — | — | — | — | — | — | $12.86B | $12B | $11.77B | |
| — | — | — | — | — | — | — | — | $2.14B | $2.19B | $2.48B | |
| $17.64B | $14.54B | $9.77B | $7.95B | $10.06B | $10.15B | $9.09B | $8.4B | $8.7B | $8.27B | $8.98B | |
| $16.35B | $13.64B | $9.12B | $7.18B | $24.53B | $9.88B | $8.94B | $14.1B | $9.1B | $7.82B | $8.13B | |
| $2.39B | $1.7B | $551M | $1.13B | $1.63B | $1.81B | $1.79B | $1.3B | $1.6B | $1.12B | $1.11B | |
| $13.98B | $11.94B | $14.85B | $6.96B | $24.02B | $8.07B | $11.73B | $12.61B | $7.7B | $6.71B | $17.78B | |
| USD/shares | $7.21 | $5.92 | $7.15 | $3.19 | $10.71 | $3.55 | $5.12 | $5.44 | $3.28 | $2.82 | $7.40 |
| USD/shares | $7.15 | $5.87 | $7.10 | $3.17 | $10.63 | $3.52 | $5.06 | $5.38 | $3.25 | $2.80 | $7.29 |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2015–FY2025: $63.05B in buybacks, $77.78B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.
Key facts
CIK
1114448
CUSIP
66987V109
13F (30d)
36 filings
20 filers
Visit website
Investor relations